146 related articles for article (PubMed ID: 2445515)
1. The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio.
Risby ED; Hsiao JK; Sunderland T; Agren H; Rudorfer MV; Potter WZ
Clin Pharmacol Ther; 1987 Nov; 42(5):547-54. PubMed ID: 2445515
[TBL] [Abstract][Full Text] [Related]
2. Central neurochemical ultradian variability in depression.
Salomon RM; Johnson BW; Schmidt DE
Dis Markers; 2006; 22(1-2):65-72. PubMed ID: 16410652
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism.
Narayan M; Srinath S; Anderson GM; Meundi DB
Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):630-5. PubMed ID: 7687150
[TBL] [Abstract][Full Text] [Related]
4. CSF amine metabolites and depression.
Peabody CA; Faull KF; King RJ; Whiteford HA; Barchas JD; Berger PA
Psychiatry Res; 1987 May; 21(1):1-7. PubMed ID: 2440071
[TBL] [Abstract][Full Text] [Related]
5. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
[TBL] [Abstract][Full Text] [Related]
6. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
7. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
[TBL] [Abstract][Full Text] [Related]
8. Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF.
Agren H; Mefford IN; Rudorfer MV; Linnoila M; Potter WZ
J Psychiatr Res; 1986; 20(3):175-93. PubMed ID: 2430098
[TBL] [Abstract][Full Text] [Related]
9. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Soininen H; MacDonald E; Rekonen M; Riekkinen PJ
Acta Neurol Scand; 1981 Aug; 64(2):101-7. PubMed ID: 6172950
[TBL] [Abstract][Full Text] [Related]
10. Monoamine neurotransmitter interactions and the prediction of antidepressant response.
Hsiao JK; Agren H; Bartko JJ; Rudorfer MV; Linnoila M; Potter WZ
Arch Gen Psychiatry; 1987 Dec; 44(12):1078-83. PubMed ID: 2446588
[TBL] [Abstract][Full Text] [Related]
11. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
Mendlewicz J; Vanderheyden JE; Noel G
Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
[TBL] [Abstract][Full Text] [Related]
12. The effect of lumbar puncture stress on dopamine and serotonin metabolites in human cerebrospinal fluid.
Hill KK; West SA; Ekhator NN; Bruce AB; Wortman MD; Baker DG; Geracioti TD
Neurosci Lett; 1999 Nov; 276(1):25-8. PubMed ID: 10586966
[TBL] [Abstract][Full Text] [Related]
13. Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment.
Bäckman J; Alling C; Alsén M; Regnéll G; Träskman-Bendz L
Eur Neuropsychopharmacol; 2000 Sep; 10(5):341-9. PubMed ID: 10974605
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid amine metabolites in acute schizophrenia.
Post RM; Fink E; Carpenter WT; Goodwin FK
Arch Gen Psychiatry; 1975 Aug; 32(8):1063-9. PubMed ID: 1156113
[TBL] [Abstract][Full Text] [Related]
15. CSF amine metabolites in depression.
Reddy PL; Khanna S; Subhash MN; Channabasavanna SM; Rao BS
Biol Psychiatry; 1992 Jan; 31(2):112-8. PubMed ID: 1371076
[TBL] [Abstract][Full Text] [Related]
16. Purine and monoamine metabolites in cerebrospinal fluid: parallel purinergic and monoaminergic activation in depressive illness?
Niklasson F; Agren H; Hällgren R
J Neurol Neurosurg Psychiatry; 1983 Mar; 46(3):255-60. PubMed ID: 6188805
[TBL] [Abstract][Full Text] [Related]
17. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
Vanderheyden JE; Noel G; Mendlewicz J
Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
[TBL] [Abstract][Full Text] [Related]
18. Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.
Salomon RM; Kennedy JS; Johnson BW; Urbano Blackford J; Schmidt DE; Kwentus J; Gwirtsman HE; Gouda JF; Shiavi RG
Neuropsychopharmacology; 2005 Nov; 30(11):2082-91. PubMed ID: 15856079
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant effect of femoxetine and desipramine and relationship to the concentration of amine metabolites in cerebrospinal fluid. A double-blind evaluation.
Dahl LE; Lundin L; le Fèvre Honoré P; Dencker SJ
Acta Psychiatr Scand; 1982 Jul; 66(1):9-17. PubMed ID: 6181653
[TBL] [Abstract][Full Text] [Related]
20. Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid.
Johansson B; Roos BE
Acta Neurol Scand; 1975 Aug; 52(2):137-44. PubMed ID: 1155031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
